Reverse-vaccinology strategy for designing T-cell epitope candidates for Staphylococcus aureus endocarditis vaccine
- 1 May 2013
- journal article
- Published by Elsevier in Biologicals
- Vol. 41 (3) , 148-153
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Is there a future for a Staphylococcus aureus vaccine?Vaccine, 2012
- Increasing US Rates of Endocarditis With Staphylococcus aureus: 1999-2008Archives of internal medicine (1960), 2012
- Genetic variation in Staphylococcus aureus surface and immune evasion genes is lineage associated: implications for vaccine design and host-pathogen interactionsBMC Microbiology, 2010
- Infective endocarditisBMJ, 2006
- The changing face of infective endocarditisHeart, 2006
- Staphylococcus aureus EndocarditisJAMA, 2005
- Infective endocarditisThe Lancet, 2004
- Changing Patient Characteristics and the Effect on Mortality in EndocarditisArchives of internal medicine (1960), 2002
- Contribution of Clumping Factor B to Pathogenesis of Experimental Endocarditis due to Staphylococcus aureusInfection and Immunity, 2000
- Collagen Binding of Staphylococcus aureus Is a Virulence Factor in Experimental EndocarditisThe Journal of Infectious Diseases, 1996